# Flurazepam Hydrochloride Capsule: FDA shortage status

> FDA source status only. Nationwide status is not local pharmacy inventory. This page does not provide medical, treatment, substitution, or dosing advice.

- Derived status: current
- Source statuses: Current
- FDA package records: 6
- Latest FDA row update: 08/04/2026
- Retrieved: 2026-08-22T15:54:11+00:00

## FDA package and manufacturer records

- Chartwell Molecular Holdings LLC — Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-30) — FDA availability: Available — updated: 08/04/2026
- Chartwell Molecular Holdings LLC — Flurazepam Hydrochloride, Capsule, 15 mg (NDC 62135-736-90) — FDA availability: Available — updated: 08/04/2026
- Chartwell Molecular Holdings LLC — Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-30) — FDA availability: Available — updated: 08/04/2026
- Chartwell Molecular Holdings LLC — Flurazepam Hydrochloride, Capsule, 30 mg (NDC 62135-737-90) — FDA availability: Available — updated: 08/04/2026
- Rising Pharma Holdings, Inc. — Flurazepam Hydrochloride, Capsule, 15 mg (NDC 0378-4415-01) — FDA availability: Unavailable — updated: 06/03/2026
- Rising Pharma Holdings, Inc. — Flurazepam Hydrochloride, Capsule, 30 mg (NDC 0378-4430-01) — FDA availability: Unavailable — updated: 06/03/2026

## Sources and formats

- [FDA openFDA source](https://api.fda.gov/drug/shortages.json)
- [Canonical HTML](https://citefacts.com/shortages/flurazepam-hydrochloride-capsule)
- [JSON record](https://citefacts.com/shortages/flurazepam-hydrochloride-capsule.json)